IPIX is not current in filing financials on schedu
Post# of 72447
(Total Views: 992)
Posted On: 04/19/2024 5:33:09 PM
IPIX is not current in filing financials on schedule and are now traded on the “Expert Market” where the MMs are supposed to only take unsolicited orders with limited quotation information to retail buyers. IMO, this is the classic “Fox guarding the chicken coop”. The MMs didn't waste any time further crushing SP down from .0177 to .0045 in a couple of days. This will continue until IPIX updates their current financials.
On a positive note this post from a different board makes for an intriguing connect the dots exercise.
===================
The law firm representing BT Beamedical sounds interesting! One of the best law firms in Israel with strong M&A focus in the international Healthcare and Life Science sector.
And BT Beamed is listed as one of their key clients.
The team at Amit, Pollak, Matalon & Co. Advocates and Notary regularly assists with equity investments and data privacy compliance mandates. Practice co-head Ian Rostowsky is particularly adept at handling fund formation and M&A-related issues within the sector,
Work highlights: Represented F.O.R.E Biotherapeutics in an equity investment transaction and is currently dealing with a merger which will result in the company being flipped from Israel to become a Delaware corporation.
https://www.legal500.com/c/israel/healthcare-...chnologies
On a positive note this post from a different board makes for an intriguing connect the dots exercise.
===================
The law firm representing BT Beamedical sounds interesting! One of the best law firms in Israel with strong M&A focus in the international Healthcare and Life Science sector.
And BT Beamed is listed as one of their key clients.
The team at Amit, Pollak, Matalon & Co. Advocates and Notary regularly assists with equity investments and data privacy compliance mandates. Practice co-head Ian Rostowsky is particularly adept at handling fund formation and M&A-related issues within the sector,
Work highlights: Represented F.O.R.E Biotherapeutics in an equity investment transaction and is currently dealing with a merger which will result in the company being flipped from Israel to become a Delaware corporation.
https://www.legal500.com/c/israel/healthcare-...chnologies
(8)
(1)